NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for LYRICA ®. This grant extends the period of U.S ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback